Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

MedMira Inc V.MIR

Alternate Symbol(s):  MMIRF

MedMira Inc. is a Canada-based biotechnology company. The Company, through its subsidiaries, is engaged in the business of research, development and manufacturing of rapid diagnostics and technologies. The Company invests in research in order to maintain and expand its position in the global diagnostics market. Its research is focused on specific areas of the broader diagnostics market, namely the rapid, point-of-care, and in vitro sectors. The Company is the developer and owner of Rapid Vertical Flow (RVF) Technology. The Company's rapid test applications built on RVF Technology provide hospitals, labs, clinics and individuals with instant diagnosis for diseases such as Human Immunodeficiency Virus (HIV), Syphilis and hepatitis C in just three easy steps. The Company's tests are sold under the Reveal, Multiplo and Miriad brands in global markets. The Company's manufacturing facilities are located in Halifax, Nova Scotia, Canada.


TSXV:MIR - Post by User

Comment by Parrotheadon Jul 16, 2020 12:29pm
221 Views
Post# 31276536

RE:ARE WE WAITING FOR MIR OR FDA ? ANYONE KNOW ?

RE:ARE WE WAITING FOR MIR OR FDA ? ANYONE KNOW ?
My understanding is that FDA has changed the requirements, so many companies have submitted test kits that have turned out to be bogus. So things are more stringent now.

First MedMira has to send kits for testing to an approved lab (or have they retested on certified test panels). Then those results with additional kits go to the FDA for additional evaluation. To pass, they need to achieve 90% (sensitivity) accuracy. I believe they have been averaging 95 to 97%. Someone posted that the product insert quoted 97.1%.

MedMira's science is rock solid, with the accurate detection of all 3 antibodies - IgA, IgG, and IgM. Just comes down to time for both MedMira and the FDA to complete the requirements. Given the rising COVID numbers in 40+ states, I am sure the FDA wants this done as soon as possible.
<< Previous
Bullboard Posts
Next >>